← All trials
NCT06063941
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 10, 2023
- Primary completion
- Apr 30, 2024
- Completion date
- Apr 30, 2024
- First posted
- Oct 3, 2023
- Last posted
- Oct 13, 2023
- Enrollment
- 450
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- People's Liberation Army of ChinaLead sponsor
- Xi'an International Medical Center HospitalCollaborator
- People's Liberation Army of ChinaOverall official - principal investigator
- People's Liberation Army of ChinaReponsible party - principal investigator
- Government of ChinaCollaborator
- People's Liberation Army of ChinaOfficial
- People's Liberation Army of ChinaSponsor investigator
- Ankang City Central HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.